Joined Zilia's bridge financing round as a new investor, supporting its non-invasive ocular biomarker platform ahead of a planned institutional raise.
Zilia is a health technology company developing a breakthrough platform to measure biomarkers in the eye, with an initial objective to help save the sight of millions
Zilia is a health technology company developing a breakthrough platform to measure biomarkers in the eye, with an initial objective to help save the sight of millions. Its flagship product, Zilia Ocular, measures oxygen saturation in the eye and has received Health Canada approval.